Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck
DJ Thomson, P Silva, K Denton, S Bonington… - Head & …, 2015 - Wiley Online Library
Background There is a need to improve the systemic treatment of advanced adenoid cystic
carcinoma (ACC). Response rates to chemotherapy are poor and preliminary investigations …
carcinoma (ACC). Response rates to chemotherapy are poor and preliminary investigations …
Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck.
DJ Thomson, P Silva, K Denton, SC Bonington, SK Mak… - 2013 - christie.openrepository.com
Background There is a need to improve the systemic treatment of advanced adenoid cystic
carcinoma (ACC). Response rates to chemotherapy are poor and preliminary investigations …
carcinoma (ACC). Response rates to chemotherapy are poor and preliminary investigations …
Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck
DJ Thomson, P Silva, K Denton, S Bonington… - Head & …, 2015 - pubmed.ncbi.nlm.nih.gov
Background There is a need to improve the systemic treatment of advanced adenoid cystic
carcinoma (ACC). Response rates to chemotherapy are poor and preliminary investigations …
carcinoma (ACC). Response rates to chemotherapy are poor and preliminary investigations …
Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck
DJ Thomson, P Silva, K Denton, S Bonington, SK Mak… - Head & Neck, 2015 - infona.pl
Background There is a need to improve the systemic treatment of advanced adenoid cystic
carcinoma (ACC). Response rates to chemotherapy are poor and preliminary investigations …
carcinoma (ACC). Response rates to chemotherapy are poor and preliminary investigations …
Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck.
DJ Thomson, P Silva, K Denton, S Bonington… - Head & …, 2014 - europepmc.org
Background There is a need to improve the systemic treatment of advanced adenoid cystic
carcinoma (ACC). Response rates to chemotherapy are poor and preliminary investigations …
carcinoma (ACC). Response rates to chemotherapy are poor and preliminary investigations …
Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck.
DJ Thomson, P Silva, K Denton, S Bonington… - Head & …, 2015 - search.ebscohost.com
Background There is a need to improve the systemic treatment of advanced adenoid cystic
carcinoma (ACC). Response rates to chemotherapy are poor and preliminary investigations …
carcinoma (ACC). Response rates to chemotherapy are poor and preliminary investigations …
Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck
DJ Thomson, P Silva, K Denton, S Bonington, SK Mak… - Head & Neck, 2014 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
There is a need to improve the systemic treatment of advanced adenoid cystic carcinoma …
There is a need to improve the systemic treatment of advanced adenoid cystic carcinoma …